139 related articles for article (PubMed ID: 24853487)
21. Non-Lethal Sonodynamic Therapy Inhibits Atherosclerotic Plaque Progression in ApoE-/- Mice and Attenuates ox-LDL-mediated Macrophage Impairment by Inducing Heme Oxygenase-1.
Wang Y; Wang W; Xu H; Sun Y; Sun J; Jiang Y; Yao J; Tian Y
Cell Physiol Biochem; 2017; 41(6):2432-2446. PubMed ID: 28468003
[TBL] [Abstract][Full Text] [Related]
22. Induction of oxidative stress by oxidized LDL via meprinα-activated epidermal growth factor receptor in macrophages.
Gao P; Wang XM; Qian DH; Qin ZX; Jin J; Xu Q; Yuan QY; Li XJ; Si LY
Cardiovasc Res; 2013 Mar; 97(3):533-43. PubMed ID: 23250920
[TBL] [Abstract][Full Text] [Related]
23. Genetic deletion of chemokine receptor Ccr6 decreases atherogenesis in ApoE-deficient mice.
Wan W; Lim JK; Lionakis MS; Rivollier A; McDermott DH; Kelsall BL; Farber JM; Murphy PM
Circ Res; 2011 Aug; 109(4):374-81. PubMed ID: 21680896
[TBL] [Abstract][Full Text] [Related]
24. Macrophage beta3 integrin suppresses hyperlipidemia-induced inflammation by modulating TNFalpha expression.
Schneider JG; Zhu Y; Coleman T; Semenkovich CF
Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2699-706. PubMed ID: 17951320
[TBL] [Abstract][Full Text] [Related]
25. Apocynin suppresses the progression of atherosclerosis in apoE-deficient mice by inactivation of macrophages.
Kinoshita H; Matsumura T; Ishii N; Fukuda K; Senokuchi T; Motoshima H; Kondo T; Taketa K; Kawasaki S; Hanatani S; Takeya M; Nishikawa T; Araki E
Biochem Biophys Res Commun; 2013 Feb; 431(2):124-30. PubMed ID: 23318172
[TBL] [Abstract][Full Text] [Related]
26. Anagliptin, a DPP-4 inhibitor, suppresses proliferation of vascular smooth muscles and monocyte inflammatory reaction and attenuates atherosclerosis in male apo E-deficient mice.
Ervinna N; Mita T; Yasunari E; Azuma K; Tanaka R; Fujimura S; Sukmawati D; Nomiyama T; Kanazawa A; Kawamori R; Fujitani Y; Watada H
Endocrinology; 2013 Mar; 154(3):1260-70. PubMed ID: 23337530
[TBL] [Abstract][Full Text] [Related]
27. Transcriptomic analysis reveals the critical role of chemokine signaling in the anti-atherosclerosis effect of Xuefu Zhuyu decoction.
Jia D; Zhao M; Zhang X; Cheng X; Wei Q; Lou L; Zhao Y; Jin Q; Chen M; Zhang D
J Ethnopharmacol; 2024 Oct; 332():118245. PubMed ID: 38679399
[TBL] [Abstract][Full Text] [Related]
28. Lactones from Ligusticum chuanxiong Hort. reduces atherosclerotic lesions in apoE-deficient mice via inhibiting over expression of NF-kB-dependent adhesion molecules.
Xiao Y; Wang YC; Li LL; Jin YC; Sironi L; Wang Y; Wang Y
Fitoterapia; 2014 Jun; 95():240-6. PubMed ID: 24594239
[TBL] [Abstract][Full Text] [Related]
29. Endogenous angiotensin II enhances atherogenesis in apoprotein E-deficient mice with renovascular hypertension through activation of vascular smooth muscle cells.
Heo HJ; Yun MR; Jung KH; Lee JY; Park JY; Lee SJ; Bae SS; Lee WS; Kim CD
Life Sci; 2007 Feb; 80(11):1057-63. PubMed ID: 17204292
[TBL] [Abstract][Full Text] [Related]
30. Tumor necrosis factor-alpha deficiency retards early fatty-streak lesion by influencing the expression of inflammatory factors in apoE-null mice.
Xiao N; Yin M; Zhang L; Qu X; Du H; Sun X; Mao L; Ren G; Zhang C; Geng Y; An L; Pan J
Mol Genet Metab; 2009 Apr; 96(4):239-44. PubMed ID: 19157944
[TBL] [Abstract][Full Text] [Related]
31. Danhong injection inhibits the development of atherosclerosis in both Apoe⁻/⁻ and Ldlr⁻/⁻ mice.
Chen Y; Liu M; Zhao T; Zhao B; Jia L; Zhu Y; Zhang B; Gao X; Li G; Li X; Xiang R; Han J; Duan Y
J Cardiovasc Pharmacol; 2014 May; 63(5):441-52. PubMed ID: 24803317
[TBL] [Abstract][Full Text] [Related]
32. Disruption of tumor necrosis factor-alpha gene diminishes the development of atherosclerosis in ApoE-deficient mice.
Ohta H; Wada H; Niwa T; Kirii H; Iwamoto N; Fujii H; Saito K; Sekikawa K; Seishima M
Atherosclerosis; 2005 May; 180(1):11-7. PubMed ID: 15823270
[TBL] [Abstract][Full Text] [Related]
33. Microrna-145 accelerates the inflammatory reaction through activation of NF-κB signaling in atherosclerosis cells and mice.
Li S; Sun W; Zheng H; Tian F
Biomed Pharmacother; 2018 Jul; 103():851-857. PubMed ID: 29710501
[TBL] [Abstract][Full Text] [Related]
34. Poly(ADP-ribose) polymerase inhibition reduces atherosclerotic plaque size and promotes factors of plaque stability in apolipoprotein E-deficient mice: effects on macrophage recruitment, nuclear factor-kappaB nuclear translocation, and foam cell death.
Oumouna-Benachour K; Hans CP; Suzuki Y; Naura A; Datta R; Belmadani S; Fallon K; Woods C; Boulares AH
Circulation; 2007 May; 115(18):2442-50. PubMed ID: 17438151
[TBL] [Abstract][Full Text] [Related]
35. High-dose recombinant apolipoprotein A-I(milano) mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein e-deficient mice. Potential implications for acute plaque stabilization.
Shah PK; Yano J; Reyes O; Chyu KY; Kaul S; Bisgaier CL; Drake S; Cercek B
Circulation; 2001 Jun; 103(25):3047-50. PubMed ID: 11425766
[TBL] [Abstract][Full Text] [Related]
36. HMGB1 expression and secretion are increased via TWEAK-Fn14 interaction in atherosclerotic plaques and cultured monocytes.
Moreno JA; Sastre C; Madrigal-Matute J; Muñoz-García B; Ortega L; Burkly LC; Egido J; Martín-Ventura JL; Blanco-Colio LM
Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):612-20. PubMed ID: 23288170
[TBL] [Abstract][Full Text] [Related]
37. Endothelin-1 overexpression exacerbates atherosclerosis and induces aortic aneurysms in apolipoprotein E knockout mice.
Li MW; Mian MO; Barhoumi T; Rehman A; Mann K; Paradis P; Schiffrin EL
Arterioscler Thromb Vasc Biol; 2013 Oct; 33(10):2306-15. PubMed ID: 23887640
[TBL] [Abstract][Full Text] [Related]
38. The Anti-Atherosclerotic Effects of Buyang Huanwu Decoction through M1 and M2 Macrophage Polarization in an ApoE Knockout Mouse Model.
Ji M; Mao L; Wei Y; Zhu B; Zhai Y; Zhou X; Tao W; Wang W; Wu H
J Physiol Investig; 2024 Mar; 67(2):79-87. PubMed ID: 38780292
[TBL] [Abstract][Full Text] [Related]
39. Reduced atherosclerotic lesions in P2Y1/apolipoprotein E double-knockout mice: the contribution of non-hematopoietic-derived P2Y1 receptors.
Hechler B; Freund M; Ravanat C; Magnenat S; Cazenave JP; Gachet C
Circulation; 2008 Aug; 118(7):754-63. PubMed ID: 18663083
[TBL] [Abstract][Full Text] [Related]
40. The role of the scavenger receptor CD36 in regulating mononuclear phagocyte trafficking to atherosclerotic lesions and vascular inflammation.
Harb D; Bujold K; Febbraio M; Sirois MG; Ong H; Marleau S
Cardiovasc Res; 2009 Jul; 83(1):42-51. PubMed ID: 19264766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
